Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “nilotinib”

4 pharma patents match "nilotinib" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "nilotinib" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “nilotinib” · 30,257 patents in full index Clear search

  1. US 10640487

    Solid state forms of Nilotinib salts

    Teva Pharmaceuticals USA, Inc. · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  2. US 9090598

    Nilotinib salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  3. US 8937082

    Nilotinib salts and crystalline forms thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  4. US 8592442

    Nilotinib HCl crystalline forms

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.